Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019
- Paoletti, Costanza
- Li, Yufeng
- Muñiz, Maria C.
- Kidwell, Kelley M.
- Aung, Kimberly
- Thomas, Dafydd G.
- Brown, Martha E.
- Abramson, Vandana G.
- Irvin, William J.
- Lin, Nancy U.
- Liu, Minetta C.
- Nanda, Rita
- Nangia, Julie R.
- Storniolo, Anna M.
- Traina, Tiffany A.
- Vaklavas, Christos
- Van Poznak, Catherine H.
- Wolff, Antonio C.
- Forero-Torres, Andres
- Hayes, Daniel F.
Publication date
January 2015
DOIAbstract
Circulating Tumor cells (CTC) are prognostic in metastatic breast cancer (MBC). We tested whether the EpCAM based capture system (CellSearch®) is effective in patients with triple negative (TN) MBC, and whether CTC-apoptosis and clustering enhances the prognostic role of CTC
Add to ORKG